HEADER TRANSFERASE 11-AUG-14 4UWB TITLE FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE IN COMPLEX WITH JK-P5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 458-765; COMPND 5 SYNONYM: FGFR-1, BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1, BFGFR, COMPND 6 BFGF-R-1, FMS-LIKE TYROSINE KINASE 2, FLT-2, N-SAM, PROTO-ONCOGENE C- COMPND 7 FGR, FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: STAR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PET28 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.BEESTON,J.TUCKER,J.KANKANALA REVDAT 5 01-MAY-24 4UWB 1 REMARK REVDAT 4 16-JUN-21 4UWB 1 JRNL REMARK REVDAT 3 04-APR-18 4UWB 1 REMARK REVDAT 2 29-MAR-17 4UWB 1 REMARK REVDAT 1 02-SEP-15 4UWB 0 JRNL AUTH H.S.BEESTON,T.KLEIN,R.A.NORMAN,J.A.TUCKER,M.ANDERSON, JRNL AUTH 2 A.E.ASHCROFT,G.A.HOLDGATE JRNL TITL VALIDATION OF IMS-MS AS A SCREENING TOOL TO IDENTIFY TYPE II JRNL TITL 2 KINASE INHIBITORS OF FGFR1 KINASE. JRNL REF RAPID COMMUN MASS SPECTROM E9130 2021 JRNL REFN ISSN 1097-0231 JRNL PMID 34038603 JRNL DOI 10.1002/RCM.9130 REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 99.44 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 29915 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1598 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.31 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.37 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1988 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.12 REMARK 3 BIN R VALUE (WORKING SET) : 0.2700 REMARK 3 BIN FREE R VALUE SET COUNT : 109 REMARK 3 BIN FREE R VALUE : 0.2900 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4652 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 193 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.02000 REMARK 3 B22 (A**2) : 4.19000 REMARK 3 B33 (A**2) : -1.95000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.27000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.379 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.263 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.226 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 18.136 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.924 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.896 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4835 ; 0.011 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6541 ; 1.499 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 593 ; 6.136 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 199 ;37.610 ;24.121 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 829 ;15.953 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 29 ;15.708 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 719 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3598 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 464 A 765 REMARK 3 ORIGIN FOR THE GROUP (A): 80.5079 -2.5387 17.7971 REMARK 3 T TENSOR REMARK 3 T11: 0.1046 T22: 0.0386 REMARK 3 T33: 0.0278 T12: -0.0003 REMARK 3 T13: 0.0005 T23: 0.0212 REMARK 3 L TENSOR REMARK 3 L11: 4.1339 L22: 0.7570 REMARK 3 L33: 1.6075 L12: -0.0002 REMARK 3 L13: -1.1944 L23: -0.4220 REMARK 3 S TENSOR REMARK 3 S11: 0.1018 S12: 0.2082 S13: 0.3274 REMARK 3 S21: -0.1300 S22: -0.0199 S23: 0.0249 REMARK 3 S31: -0.2012 S32: 0.0642 S33: -0.0819 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 459 B 765 REMARK 3 ORIGIN FOR THE GROUP (A): 34.8936 1.3883 14.3501 REMARK 3 T TENSOR REMARK 3 T11: 0.1390 T22: 0.0680 REMARK 3 T33: 0.0633 T12: -0.0044 REMARK 3 T13: -0.0501 T23: -0.0158 REMARK 3 L TENSOR REMARK 3 L11: 4.2174 L22: 1.1085 REMARK 3 L33: 1.3827 L12: -1.2509 REMARK 3 L13: -0.6655 L23: 0.4955 REMARK 3 S TENSOR REMARK 3 S11: 0.1787 S12: 0.2335 S13: -0.2385 REMARK 3 S21: 0.1419 S22: -0.2116 S23: 0.0443 REMARK 3 S31: 0.1390 S32: 0.0790 S33: 0.0329 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES WITH TLS ADDED. HYDROGENS HAVE BEEN USED IF REMARK 3 PRESENT IN THE INPUT. DISORDERED SIDE-CHAINS WERE TRUNCATED TO REMARK 3 THE LAST VISIBLE ATOM REMARK 4 REMARK 4 4UWB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-AUG-14. REMARK 100 THE DEPOSITION ID IS D_1290061474. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.541780 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC, XDS VERSION MARCH 15 REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29915 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 99.440 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.48000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: INTERNAL FGFR1 MODEL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG8000, 20% ETHLYENE GLYCOL, 0.2M REMARK 280 AMMONIUM SULPHATE, 0.1M PCTP PH 6.75 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 104.31150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.66150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 104.31150 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.66150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 457 REMARK 465 ALA A 458 REMARK 465 GLY A 459 REMARK 465 VAL A 460 REMARK 465 SER A 461 REMARK 465 GLU A 462 REMARK 465 TYR A 463 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 ILE A 648 REMARK 465 GLY B 457 REMARK 465 ALA B 458 REMARK 465 ASP B 503 REMARK 465 LYS B 504 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 464 CG CD OE1 OE2 REMARK 470 GLU A 486 CG CD OE1 OE2 REMARK 470 PHE A 489 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 502 CG CD CE NZ REMARK 470 ASP A 503 CG OD1 OD2 REMARK 470 ARG A 507 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 519 CG OD1 OD2 REMARK 470 GLU A 522 CG CD OE1 OE2 REMARK 470 LEU A 581 CG CD1 CD2 REMARK 470 ASN A 590 CG OD1 ND2 REMARK 470 GLU A 592 CG CD OE1 OE2 REMARK 470 ARG A 646 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 649 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 650 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 655 CG CD CE NZ REMARK 470 ARG A 675 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 467 CG CD OE1 OE2 REMARK 470 LYS B 502 CG CD CE NZ REMARK 470 ASN B 506 CG OD1 ND2 REMARK 470 ARG B 507 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 522 CG CD OE1 OE2 REMARK 470 TYR B 583 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU B 592 CG CD OE1 OE2 REMARK 470 LYS B 618 CD CE NZ REMARK 470 ILE B 651 CG1 CG2 CD1 REMARK 470 LYS B 655 CD CE NZ REMARK 470 ASN B 724 CG OD1 ND2 REMARK 470 ARG B 756 CD NE CZ NH1 NH2 REMARK 470 ASN B 763 CG OD1 ND2 REMARK 470 GLN B 764 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 616 O HOH A 2047 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 502 -61.71 -27.00 REMARK 500 SER A 518 -75.69 -64.47 REMARK 500 PRO A 579 151.68 -48.38 REMARK 500 GLU A 582 -32.37 -30.03 REMARK 500 HIS A 589 69.16 -68.96 REMARK 500 ARG A 622 -18.23 79.69 REMARK 500 ARG A 646 -90.41 -43.16 REMARK 500 SER B 461 -8.42 -56.79 REMARK 500 ASP B 501 -164.96 -119.37 REMARK 500 PRO B 578 163.23 -46.88 REMARK 500 LEU B 581 25.62 -74.81 REMARK 500 ARG B 622 -25.36 84.10 REMARK 500 GLN B 764 -80.82 -120.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A3082 DISTANCE = 6.00 ANGSTROMS REMARK 525 HOH A3083 DISTANCE = 6.33 ANGSTROMS REMARK 525 HOH B2084 DISTANCE = 5.88 ANGSTROMS REMARK 525 HOH B2085 DISTANCE = 8.73 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1766 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1766 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1767 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1767 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1768 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JVT B 1768 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JVT A 1769 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1770 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1769 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UWC RELATED DB: PDB REMARK 900 FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE IN COMPLEX WITH JK-P3 REMARK 999 REMARK 999 SEQUENCE REMARK 999 TWO MUTATIONS TO IMPROVE CRYSTALLISATION AND REDUCE REMARK 999 AGGREGATION C488A AND C584S DBREF 4UWB A 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 4UWB B 458 765 UNP P11362 FGFR1_HUMAN 458 765 SEQADV 4UWB GLY A 457 UNP P11362 EXPRESSION TAG SEQADV 4UWB ALA A 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 4UWB SER A 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQADV 4UWB GLY B 457 UNP P11362 EXPRESSION TAG SEQADV 4UWB ALA B 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 4UWB SER B 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQRES 1 A 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 A 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 A 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 A 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 A 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 A 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 A 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 A 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 A 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 A 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 A 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 A 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 A 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 A 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 A 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 A 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 A 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 A 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 A 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 A 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 A 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 A 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 A 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 A 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 B 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 B 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 B 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 B 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 B 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 B 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 B 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 B 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 B 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 B 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 B 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 B 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 B 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 B 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 B 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 B 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 B 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 B 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 B 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 B 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 B 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 B 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 B 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU HET EDO A1766 4 HET EDO A1767 4 HET EDO A1768 4 HET JVT A1769 25 HET SO4 A1770 5 HET EDO B1766 4 HET EDO B1767 4 HET JVT B1768 25 HET SO4 B1769 5 HETNAM EDO 1,2-ETHANEDIOL HETNAM JVT N-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-INDAZOLE-3- HETNAM 2 JVT CARBOXAMIDE HETNAM SO4 SULFATE ION HETSYN EDO ETHYLENE GLYCOL FORMUL 3 EDO 5(C2 H6 O2) FORMUL 6 JVT 2(C19 H21 N5 O) FORMUL 7 SO4 2(O4 S 2-) FORMUL 12 HOH *193(H2 O) HELIX 1 1 PRO A 474 ASP A 476 5 3 HELIX 2 2 THR A 521 GLY A 539 1 19 HELIX 3 3 ASN A 568 ARG A 576 1 9 HELIX 4 4 SER A 596 LYS A 617 1 22 HELIX 5 5 ALA A 625 ARG A 627 5 3 HELIX 6 6 LEU A 662 MET A 667 5 6 HELIX 7 7 ALA A 668 ARG A 675 1 8 HELIX 8 8 THR A 678 THR A 695 1 18 HELIX 9 9 PRO A 705 GLU A 715 1 11 HELIX 10 10 THR A 726 TRP A 737 1 12 HELIX 11 11 VAL A 740 ARG A 744 5 5 HELIX 12 12 THR A 746 THR A 761 1 16 HELIX 13 13 PRO B 474 ASP B 476 5 3 HELIX 14 14 THR B 521 GLY B 539 1 19 HELIX 15 15 ASN B 568 ARG B 576 1 9 HELIX 16 16 SER B 596 LYS B 617 1 22 HELIX 17 17 ALA B 625 ARG B 627 5 3 HELIX 18 18 LEU B 662 MET B 667 5 6 HELIX 19 19 ALA B 668 ARG B 675 1 8 HELIX 20 20 THR B 678 THR B 695 1 18 HELIX 21 21 PRO B 705 GLU B 715 1 11 HELIX 22 22 THR B 726 TRP B 737 1 12 HELIX 23 23 VAL B 740 ARG B 744 5 5 HELIX 24 24 THR B 746 THR B 761 1 16 SHEET 1 AA 5 LEU A 478 GLY A 485 0 SHEET 2 AA 5 VAL A 492 ILE A 498 -1 O VAL A 492 N LEU A 484 SHEET 3 AA 5 VAL A 508 LYS A 514 -1 O THR A 509 N ALA A 497 SHEET 4 AA 5 TYR A 558 GLU A 562 -1 O VAL A 559 N LYS A 514 SHEET 5 AA 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 AB 2 VAL A 629 VAL A 631 0 SHEET 2 AB 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 BA 5 LEU B 478 GLU B 486 0 SHEET 2 BA 5 GLY B 490 ILE B 498 -1 O VAL B 492 N LEU B 484 SHEET 3 BA 5 VAL B 508 LEU B 516 -1 O THR B 509 N ALA B 497 SHEET 4 BA 5 TYR B 558 GLU B 562 -1 O VAL B 559 N LYS B 514 SHEET 5 BA 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 BB 2 VAL B 629 VAL B 631 0 SHEET 2 BB 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 CISPEP 1 GLU A 486 GLY A 487 0 3.98 CISPEP 2 ASP A 503 LYS A 504 0 8.33 SITE 1 AC1 6 GLU B 531 MET B 535 ASP B 641 PHE B 642 SITE 2 AC1 6 GLY B 643 HOH B2018 SITE 1 AC2 5 GLU A 531 ALA A 640 ASP A 641 PHE A 642 SITE 2 AC2 5 GLY A 643 SITE 1 AC3 6 MET B 535 GLY B 539 LYS B 540 ILE B 544 SITE 2 AC3 6 ASN B 546 LEU B 547 SITE 1 AC4 5 TRP A 684 ARG A 718 MET A 719 TRP A 737 SITE 2 AC4 5 HOH A2066 SITE 1 AC5 5 ALA A 615 HIS A 679 THR A 746 PHE A 747 SITE 2 AC5 5 LYS A 748 SITE 1 AC6 7 LEU B 484 VAL B 561 GLU B 562 ALA B 564 SITE 2 AC6 7 SER B 565 GLY B 567 LEU B 630 SITE 1 AC7 9 LEU A 484 ALA A 512 VAL A 561 GLU A 562 SITE 2 AC7 9 ALA A 564 SER A 565 GLY A 567 LEU A 630 SITE 3 AC7 9 HOH A2031 SITE 1 AC8 6 ARG A 570 ARG A 627 THR A 657 ASN A 659 SITE 2 AC8 6 ARG A 661 HOH A2057 SITE 1 AC9 6 ARG B 570 ARG B 627 THR B 657 ASN B 659 SITE 2 AC9 6 ARG B 661 HOH B2054 CRYST1 208.623 57.323 65.628 90.00 107.58 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004793 0.000000 0.001519 0.00000 SCALE2 0.000000 0.017445 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015984 0.00000 MTRIX1 1 -0.993870 0.110020 0.010930 115.21663 1 MTRIX2 1 0.097670 0.827360 0.553110 -14.36697 1 MTRIX3 1 0.051820 -0.550790 -0.833040 27.39198 1